<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04962776</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 00006379//10-7-2021</org_study_id>
    <nct_id>NCT04962776</nct_id>
  </id_info>
  <brief_title>Preoperative Coadministration of Low-concentration Carbohydrate and Nitrates Loading vs Low- Concentration Carbohydrate Loading Alone in Patients Undergoing Open Gynecological Surgeries</brief_title>
  <official_title>A Randomised Controlled Study of Preoperative Coadministration of Low-concentration Carbohydrate and Nitrates Loading vs Low- Concentration Carbohydrate Loading Alone in Patients Undergoing Open Gynecological Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery is known to be associated with stress response affecting in a negative way the&#xD;
      clinical outcome and patient experience. The stress response includes both sympathetic&#xD;
      nervous system activation and systemic inflammatory response. The pituitary- sympathetic one&#xD;
      leads to a number of metabolic changes as hyperglycemia, nitrogen loss and lipolysis on the&#xD;
      other hand the systemic inflammatory response aggravates the perioperative metabolic changes.&#xD;
      One of components of ERAS is preoperative carbohydrate load. Oral carbohydrate was associated&#xD;
      with attenuation of the postoperative metabolic stress response. Nitrate rich drinks before&#xD;
      exercises have a promising impact due to improving blood flow, mitochondrial efficiency,&#xD;
      glucose uptake and the sarcoplasmic calcium handling all of which maximize resistance to&#xD;
      fatigue and improved exercise performance.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The length of hospital stay (Days)</measure>
    <time_frame>The study end point will be 7 days from the operation or when patient will be discharged from hospital which of which will be earlier.</time_frame>
    <description>The length of hospital stay (Days)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Length of Hospital Stay</condition>
  <arm_group>
    <arm_group_label>Low-concentration carbohydrate and nitrates group (CHON group )</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-concentration carbohydrate group (CHO group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>W group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-concentration carbohydrate and nitrates</intervention_name>
    <description>Patients in the CHON group will be given 400 mL of a clear carbohydrate drink (12.5 g/100 mL maltodextrin, 50 kcal/100 mL) and 2 capsules of beet root extract 1 gm on the evening before surgery (8 hours) and another 200 mL of the carbohydrate drink and 1 capsule of beet root extract 1 gm on the day of surgery, 2 h before anesthesia induction.</description>
    <arm_group_label>Low-concentration carbohydrate and nitrates group (CHON group )</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-concentration carbohydrate</intervention_name>
    <description>Patients in the CHO group will be given the same carbohydrate drink in the CHON group with 2 placebo capsules with the evening drink and one with the morning drink.</description>
    <arm_group_label>Low-concentration carbohydrate group (CHO group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Water with placebo capsules</intervention_name>
    <description>Patients in the W group will be given equivalent volume of drinking water with placebo capsules by evening and in the morning of surgery.</description>
    <arm_group_label>W group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients ageing from 18 to 60 years,&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) physical status I,II&#xD;
&#xD;
          -  scheduled for elective open gynecological surgeries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients with&#xD;
&#xD;
          -  Previous chemotherapy treatment,&#xD;
&#xD;
          -  Disseminated malignant disease,&#xD;
&#xD;
          -  BMI more than 40,&#xD;
&#xD;
          -  Known allergy to one or more of the study medications&#xD;
&#xD;
          -  Refusal to participate in the study&#xD;
&#xD;
          -  Patients diagnosed with diabetes milieus either type I or type II,&#xD;
&#xD;
          -  Patients with previous bariatric surgeries&#xD;
&#xD;
          -  Patients under medications that delay gastric emptying (tricyclic anti-depressants,&#xD;
             chronic use of laxatives)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ibrahim Mamdouh Esmat</last_name>
    <phone>01001241928</phone>
    <email>ibrahim_mamdouh@med.asu.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tarek Mohamed Ashoor</last_name>
    <email>tarekashoor@med.asu.edu.eg</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ain-Shams University Hospitals</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim Mamdouh Esmat</last_name>
      <phone>01001241928</phone>
      <email>ibrahim_mamdouh@med.asu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 10, 2021</study_first_submitted>
  <study_first_submitted_qc>July 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 15, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Dr.Ibrahim Mamdouh Esmat</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesia and Intensive Care Department, Faculty of Medicine, Ain- shams University, Cairo, Egypt.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

